STRATA Skin Sciences (NASDAQ:SSKN) Posts Earnings Results, Misses Estimates By $0.73 EPS

STRATA Skin Sciences (NASDAQ:SSKN) released its quarterly earnings results on Thursday. The medical device company reported ($1.13) EPS for the quarter, missing the consensus estimate of ($0.40) by ($0.73), Zacks reports. STRATA Skin Sciences had a negative return on equity of 69.33% and a negative net margin of 28.72%. The company had revenue of $33.56 million during the quarter, compared to the consensus estimate of $9.03 million.

STRATA Skin Sciences Price Performance

NASDAQ SSKN opened at $2.64 on Friday. The firm’s fifty day simple moving average is $2.75 and its two-hundred day simple moving average is $2.92. The firm has a market capitalization of $11.01 million, a P/E ratio of -0.99 and a beta of 1.32. The company has a current ratio of 1.13, a quick ratio of 0.94 and a debt-to-equity ratio of 1.62. STRATA Skin Sciences has a 12-month low of $2.51 and a 12-month high of $5.90.

Wall Street Analysts Forecast Growth

Separately, Maxim Group initiated coverage on shares of STRATA Skin Sciences in a report on Thursday, February 27th. They issued a “buy” rating and a $6.00 target price for the company.

About STRATA Skin Sciences

STRATA Skin Sciences, Inc, a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. The company operates in two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment.